Barclays’s Passage Bio PASG Stock Holding History
Bought
Maintained
Sold
Other funds holding PASG
LCM
Barclays's PASG Position: Q3 2026 in Review
Barclays increased its Passage Bio (PASG) stake by 0.94% in Q3 2026, buying an estimated $9 and bringing the position to 214 shares worth $963. The position accounts for ﹤0.01% of the portfolio, ranked #4973.
Barclays first reported a position in PASG in Q1 2022 and has held it in 19 quarters since. The position peaked at $62K in Q1 2022. 29 funds tracked by Wall St. Rank hold PASG as of Q3 2026.
- Barclays held 214 shares of Passage Bio worth $963 as of Q3 2026.
- Barclays bought 2 Passage Bio shares in Q3 2026, an estimated $9.
- Passage Bio made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4973 holding.
- Barclays first reported a position in Passage Bio in Q1 2022 and has held it in 19 quarters since.
- Barclays's Passage Bio position peaked at $62K in Q1 2022.
- 29 funds tracked by Wall St. Rank held Passage Bio as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.